Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize. The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. CTI seeks partners to co-develop drugs in various stages in our pipeline.
To receive press releases, quarterly and annual SEC filings, please click here.
For more information:
David Donlin
The Cervelle Group, LLC.
855 E. Plant Street Suite 1700
Winter Garden, FL 34787
Tel: 407-614-5959 ext. 223
Fax: 407-614-5960
E-mail: info@thecervellegroup.com
Press Room
